Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Reporting Randomised Clinical Trials of Analgesics After Traumatic or Orthopaedic Surgery is Inadequ
Link ID 22750
Title Reporting Randomised Clinical Trials of Analgesics After Traumatic or Orthopaedic Surgery is Inadequ
Url http://www.medscape.com/viewarticle/716553?src=rss
Description A review evaluates the quality of trials on analgesic use post orthopedic or traumatic surgery. BMC Clinical Pharmacology
Category Articles > Pharmacists
Keywords
Date Feb 25, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Pharmacists
1. Left Bundle Branch Block Predicts Super-Response to Cardiac Resynchronization
  Left bundle branch block is linked with a better response to cardiac resynchronization therapy (CRT), a new study shows. Reuters Health Information
Category:   Articles > Pharmacists


2. Calcium Intake: More Is Not BetterCalcium Intake: More Is Not Better
  Dr. JoAnn Manson warns that many women might be taking too much calcium -- when both diet and supplements are considered -- and explains why this is dangerous. br / iMedscape Ob/Gyn/i
Category:   Articles > Pharmacists


3. Sertraline Does Not Relieve Depression in Alzheimer Patients
  The selective serotonin reuptake inhibitor (SSRI) sertraline does not improve depression in patients with Alzheimer disease, according to a report in the February 2nd American Journal of Geriatric Psychiatry. Reuters Health Information
Category:   Articles > Pharmacists


4. Benefits Shown for Omalizumab in Uncontrolled Asthma
  The population of asthmatic people who benefit from omalizumab therapy can be extended to include those with moderate disease and those with severe, difficult-to-control asthma. Medscape Medical News
Category:   Articles > Pharmacists


5. Linagliptin Bests Glimepiride in Reducing CV RiskLinagliptin Bests Glimepiride in Reducing CV Risk
  In a randomized trial and metaanalysis, linagliptin showed better cardiovascular (CV) outcomes than its comparators, including glimepiride. br / iMedscape Medical News/i
Category:   Articles > Pharmacists




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS